Systematic review of fibroblastic rheumatism: A case report

Table 3 Laboratory findings in patients with fibroblastic rheumatism with available data

Laboratory data	Expressed levels	Number of patients with available data (n/N, %)
ANAs	+	3/31 (96.88)
	-	28/31 (96.88)
ds-DNA	+	0/18 (56.25)
	-	18/18 (56.25)
ANCA	+	3/23 (71.88)
	-	20/23 (71.88)
Anti-SSB	+	1/15 (46.88)
	-	14/15 (46.88)
Anti-Scl-70	+	0/17 (53.13)
	-	17/17 (53.13)
Anti-Jo-1	+	0/21 (65.63)
	-	21/21 (65.63)
C3	+	0/13 (40.63)
	-	13/13 (40.63)
RF	+	0/33 (100)
	-	33/33 (100)
CRP	+	4/25 (78.13)
	-	21/25 (78.13)

ANAs: Antinuclear antibodies; ANCA: Anti-neutrophil cytoplasmic antibodies; RF: Rheumatoid factor; CRP: C reactive protein.